Reduction in HCV incidence among injection drug users attending needle and syringe programs in Australia: a linkage study.

OBJECTIVES We examined trends in HCV incident infection among injection drug users (IDUs) attending needle and syringe programs (NSPs) in Australia in 1995 to 2010. METHODS We created a passive retrospective cohort of 724 IDUs who tested negative for HCV antibodies by a simple deterministic method linking partial identifiers to find repeat respondents in annual cross-sectional serosurveillance. RESULTS We identified 180 HCV seroconversions over the study period, for a pooled incidence density of 17.0 per 100 person-years (95% confidence interval [CI] = 14.68, 19.66). Incidence density declined, from a high of 30.8 per 100 person-years (95% CI = 21.3, 44.6) in 2003 to a low of 4.0 (95% CI = 1.3, 12.3) in 2009. CONCLUSIONS A decline in HCV incidence among Australian IDUs attending NSPs coincided with considerable expansion of harm reduction programs and a likely reduction in the number of IDUs, associated with significant changes in drug markets. Our results demonstrate the capacity of repeat cross-sectional serosurveillance to monitor trends in HCV incidence and provide a platform from which to assess the impact of prevention and treatment interventions.

[1]  David P. Wilson,et al.  Estimating the cost-effectiveness of needle-syringe programs in Australia , 2012, AIDS.

[2]  A. Lok,et al.  Viral hepatitis at a crossroad. , 2012, Gastroenterology.

[3]  T. Liang,et al.  Hepatitis C: The End of the Beginning and Possibly the Beginning of the End , 2012, Annals of Internal Medicine.

[4]  R. Monina Klevens,et al.  The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007 , 2012, Annals of Internal Medicine.

[5]  J. Parry,et al.  The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. , 2011, Addiction.

[6]  Louisa Degenhardt,et al.  Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews , 2011, The Lancet.

[7]  D. Osmond,et al.  Recent decline in the incidence of human immunodeficiency virus infection among California men who have sex with men. , 2011, American journal of epidemiology.

[8]  D. D. Des Jarlais,et al.  Systematic Review and Meta-Analysis of Interventions to Prevent Hepatitis C Virus Infection in People Who Inject Drugs , 2011 .

[9]  D. Vlahov,et al.  Changes in blood-borne infection risk among injection drug users. , 2011, The Journal of infectious diseases.

[10]  D. Lavanchy,et al.  Evolving epidemiology of hepatitis C virus. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[11]  T. Rhodes,et al.  Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. , 2010, Addiction.

[12]  C. Treloar,et al.  Is point of access to needles and syringes related to needle sharing? Comparing data collected from pharmacies and needle and syringe programs in south-east Sydney. , 2010, Drug and alcohol review.

[13]  J. Kaldor,et al.  Incidence and risk for acute hepatitis C infection during imprisonment in Australia , 2010, European Journal of Epidemiology.

[14]  J. Raffa,et al.  Low uptake of treatment for hepatitis C virus infection in a large community‐based study of inner city residents , 2009, Journal of viral hepatitis.

[15]  Margaret Hellard,et al.  High incidence of hepatitis C virus reinfection in a cohort of injecting drug users , 2008, Hepatology.

[16]  D. D. Des Jarlais,et al.  Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place. , 2008, American journal of epidemiology.

[17]  J. Kaldor,et al.  Representativeness of Injecting Drug Users Who Participate in HIV Surveillance: Results From Australia's Needle and Syringe Program Survey , 2008, Journal of acquired immune deficiency syndromes.

[18]  J. Kaldor,et al.  Modelling the hepatitis C virus epidemic in Australia. , 2007, Drug and alcohol dependence.

[19]  T. Rhodes,et al.  Global estimates of prevalence of HCV infection among injecting drug users. , 2007, The International journal on drug policy.

[20]  R. Coutinho,et al.  Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users , 2007, Addiction.

[21]  J. Kaldor,et al.  Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia. , 2007, Drug and alcohol dependence.

[22]  C. Treloar,et al.  Prisons, hepatitis C and harm minimisation , 2007, The Medical journal of Australia.

[23]  B. Berkhout,et al.  Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users , 2007, European Journal of Epidemiology.

[24]  J. Kaldor,et al.  The 2004 Australian prison entrants' blood‐borne virus and risk behaviour survey , 2007, Australian and New Zealand journal of public health.

[25]  J. Kaldor,et al.  High hepatitis C incidence in new injecting drug users: a policy failure? , 2007, Australian and New Zealand journal of public health.

[26]  Rohan Jayasuriya,et al.  Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. , 2006, Addiction.

[27]  C. Treloar,et al.  Comparison of needle and syringe programme attendees and non-attendees from a high drug-using area in Sydney, New South Wales. , 2006, Drug and alcohol review.

[28]  C. Treloar,et al.  Risk practices and other characteristics of injecting drug users who obtain injecting equipment from pharmacies and personal networks , 2006 .

[29]  L. Degenhardt,et al.  Changes in the initiation of heroin use after a reduction in heroin supply. , 2006, Drug and alcohol review.

[30]  W. Hall,et al.  The "lessons" of the Australian "heroin shortage" , 2006, Substance abuse treatment, prevention, and policy.

[31]  Colin W Shepard,et al.  Global epidemiology of hepatitis C virus infection. , 2005, The Lancet. Infectious diseases.

[32]  J. Dilley,et al.  Comparison of Three Methods to Measure HIV Incidence Among Persons Seeking Voluntary, Anonymous Counseling and Testing , 2005, Journal of acquired immune deficiency syndromes.

[33]  R. Kohn,et al.  Studies Relying on Passive Retrospective Cohorts Developed From Health Services Data Provide Biased Estimates of Incidence of Sexually Transmitted Infections , 2004, Sexually transmitted diseases.

[34]  L. Degenhardt,et al.  Effects of reduction in heroin supply on injecting drug use: analysis of data from needle and syringe programmes , 2004, BMJ : British Medical Journal.

[35]  G. Dore,et al.  Injecting behaviour of injecting drug users at needle and syringe programmes and pharmacies in Australia , 2003 .

[36]  L. Degenhardt,et al.  Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia. , 2003, Drug and alcohol dependence.

[37]  P. Dietze,et al.  Interpreting changes in heroin supply in Melbourne: droughts, gluts or cycles? , 2002, Drug and alcohol review.

[38]  A. Burchell,et al.  Increases in HIV incidence among men who have sex with men undergoing repeat diagnostic HIV testing in Ontario, Canada , 2002, AIDS.

[39]  S. Darke,et al.  A comparison of the harms associated with the injection of heroin and amphetamines. , 2000, Drug and alcohol dependence.

[40]  C. Aitken,et al.  Incidence of bloodborne virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990‐1995 , 1997, The Medical journal of Australia.

[41]  J. Kaldor,et al.  HIV prevalence and risk behaviour in needle exchange attenders: a national study , 1997 .

[42]  J. Kaewkungwal,et al.  HIV‐1 incidence determined retrospectively among drug users in Bangkok, Thailand , 1994, AIDS.